Streetbeat News

Analyst Ratings

NXST

Wells Fargo analyst Steven Cahall has maintained an Equal-Weight rating on Nexstar Media Gr (NASDAQ:NXST) but lowered the price target from $175 to $167.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:46 pm

GTN

Wells Fargo analyst Steven Cahall has maintained an Underweight rating on Gray Television (NYSE:GTN) and lowered the price target from $7 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:46 pm

XENE

Wedbush analyst Laura Chico has maintained an 'Outperform' rating on Xenon Pharmaceuticals (NASDAQ:XENE) but lowered the price target from $47 to $46.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:45 pm

WBD

Wells Fargo analyst Steven Cahall has maintained an Overweight rating on Warner Bros. Discovery (NASDAQ:WBD) but lowered the price target from $20 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:45 pm

DIS

Wells Fargo analyst Steven Cahall has maintained an Overweight rating on Walt Disney (NYSE:DIS) and raised the price target from $110 to $115.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:43 pm

ACET

Wedbush analyst Robert Driscoll has maintained an 'Outperform' rating on Adicet Bio (NASDAQ:ACET) but lowered the price target from $17 to $5.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:43 pm

CCO

Wells Fargo analyst Steven Chercover maintains an Equal-Weight rating on Clear Channel Outdoor (NYSE:CCO) and raises the price target from $1.25 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:42 pm

CTMX

Wedbush analyst Robert Driscoll maintains a Neutral rating on CytomX Therapeutics (NASDAQ:CTMX) and raises the price target from $2 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:41 pm

GXO

Wells Fargo analyst Allison Poliniak Cusic has maintained an Overweight rating on GXO Logistics (NYSE:GXO) but lowered the price target from $75 to $65.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:40 pm

ADNT

Wells Fargo analyst Colin Langan has maintained an Overweight rating on Adient (NYSE:ADNT) but lowered the price target from $49 to $41.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:39 pm